Avid Bioservices, Inc. (CDMO)
Feb 5, 2025 - CDMO was delisted (reason: acquired by GHO & Ampersand)
12.49
0.00 (0.00%)
Inactive · Last trade price on Feb 4, 2025

Avid Bioservices Financials Overview

Millions USD. Fiscal year is May - Apr.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingOct '24 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20
Revenue
150.45139.91149.27119.695.8759.7
Revenue Growth
6.75%-6.27%24.81%24.75%60.58%11.38%
Gross Profit
11.557.3231.4836.6529.313.93
Operating Income
-20.38-18.683.715.4212.24-10.59
Net Income
-152.05-140.750.26127.673.32-15.15
Earnings Per Share
-2.39-2.230.001.840.06-0.27
EPS Growth
---99.78%3127.60%--

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingOct '24 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20
Cash & Investments
35.1242.5138.54126.17169.9236.26
Total Debt
207.02207.83189.76183.03118.1926.85
Net Cash (Debt)
-171.91-165.33-151.22-56.8651.729.41
Net Cash Growth
----449.59%-70.83%
Net Cash Per Share
-2.70-2.62-2.37-0.810.870.17

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingOct '24 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20
Operating Cash Flow
5.2610.95-12.729.4731.185.83
Capital Expenditures
-14.94-31.81-77.8-56.41-9.86-3.81
Free Cash Flow
-9.68-20.85-90.53-46.9521.322.02
Free Cash Flow Growth
----957.97%-

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingOct '24 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20
Gross Margin
7.68%5.23%21.09%30.64%30.57%6.59%
Operating Margin
-13.55%-13.35%2.48%12.89%12.77%-17.73%
Pretax Margin
-23.42%-19.25%1.07%10.59%11.70%-17.53%
Profit Margin
-101.07%-100.60%0.17%106.75%3.46%-25.38%
FCF Margin
-6.43%-14.90%-60.65%-39.25%22.24%3.38%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20
PE Ratio
--4358.976.51392.42-
Forward PE
--76.8184.13194.59-
P/FCF Ratio
----61.08170.99
PS Ratio
5.283.467.566.9513.585.77